Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
Polymenidis
Z
Z
Department of Immunology, Hippokration Hospital of Thessaloniki, Aristotelian University of Thessaloniki, Hellas, Greece.
Adam
K
K
Parapanissiou
E
E
Sakellariou
G
G
Papakyriazi
E
E
Antoniadis
A
A
Papadimitriou
M
M
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality; D006085:Graft Survival / Q000276:immunology*; D006115:Greece; D015234:HLA-A Antigens / Q000276:immunology*; D015235:HLA-B Antigens / Q000276:immunology*; D006239:Haplotypes; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality; D011239:Prednisolone / Q000008:administration & dosage; D016019:Survival Analysis; D015996:Survival Rate
D015234:HLA-A Antigens; D015235:HLA-B Antigens; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine